Deep learning-based prediction of deliverable adaptive plans for MR-guided adaptive radiotherapy: A feasibility study

被引:5
|
作者
Buchanan, Laura [1 ]
Hamdan, Saleh [1 ]
Zhang, Ying [1 ]
Chen, Xinfeng [1 ]
Li, X. Allen [1 ]
机构
[1] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
adaptive radiation therapy; MR-guided adaptive radiation therapy; online replanning; real-time adaptation; deep-learning;
D O I
10.3389/fonc.2023.939951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeFast and automated plan generation is desirable in radiation therapy (RT), in particular, for MR-guided online adaptive RT (MRgOART) or real-time (intrafractional) adaptive RT (MRgRART), to reduce replanning time. The purpose of this study is to investigate the feasibility of using deep learning to quickly predict deliverable adaptive plans based on a target dose distribution for MRgOART/MRgRART. MethodsA conditional generative adversarial network (cGAN) was trained to predict the MLC leaf sequence corresponding to a target dose distribution based on reference plan created prior to MRgOART using a 1.5T MR-Linac. The training dataset included 50 ground truth dose distributions and corresponding beam parameters (aperture shapes and weights) created during MRgOART for 10 pancreatic cancer patients (each with five fractions). The model input was the dose distribution from each individual beam and the output was the predicted corresponding field segments with specific shape and weight. Patient-based leave-one-out-cross-validation was employed and for each model trained, four (44 training beams) out of five fractionated plans of the left-out patient were set aside for testing purposes. We deliberately kept a single fractionated plan in the training dataset so that the model could learn to replan the patient based on a prior plan. The model performance was evaluated by calculating the gamma passing rate of the ground truth dose vs. the dose from the predicted adaptive plan and calculating max and mean dose metrics. ResultsThe average gamma passing rate (95%, 3mm/3%) among 10 test cases was 88%. In general, we observed 95% of the prescription dose to PTV achieved with an average 7.6% increase of max and mean dose, respectively, to OARs for predicted replans. Complete adaptive plans were predicted in <= 20 s using a GTX 1660TI GPU. ConclusionWe have proposed and demonstrated a deep learning method to generate adaptive plans automatically and rapidly for MRgOART. With further developments using large datasets and the inclusion of patient contours, the method may be implemented to accelerate MRgOART process or even to facilitate MRgRART.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers
    Mulder, Samuel L.
    Heukelom, Jolien
    McDonald, Brigid A.
    Van Dijk, Lisanne
    Wahid, Kareem A.
    Sanders, Keith
    Salzillo, Travis C.
    Hemmati, Mehdi
    Schaefer, Andrew
    Fuller, Clifton D.
    CANCERS, 2022, 14 (08)
  • [42] Deep Learning for Head and Neck Segmentation in MR: A Tool for the MR-Guided Radiotherapy
    Anderson, B.
    Elsohari, B.
    Cardenas, C.
    Mohamed, A.
    Yang, P.
    Fuller, C.
    Chung, C.
    Brock, K.
    MEDICAL PHYSICS, 2018, 45 (06) : E634 - E634
  • [43] Novel Deep Learning Segmentation Models for Accurate GTV and OAR Segmentation in MR-Guided Adaptive Radiotherapy for Pancreatic Cancer Patients
    Choi, W.
    Nourzadeh, H.
    Chen, Y.
    Ainsley, C.
    Desai, V.
    Kubli, A.
    Vinogradskiy, Y.
    Mooney, K.
    Werner-Wasik, M.
    Mueller, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E462 - E462
  • [44] A film-based end-to-end test for MR-guided online adaptive radiotherapy
    Hoffmans, D.
    Bohoudi, O.
    Niebuhr, N.
    Pfaffenberger, A.
    Battum, L.
    Slotman, B.
    Palacios, M.
    Bruynzeel, A.
    Lagerwaard, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S209 - S210
  • [45] Assessment of Dose Accuracy for MR-Guided Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
    Ding, S.
    Liu, H.
    Wang, B.
    Li, Y.
    Liu, B.
    Huang, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E149 - E149
  • [46] The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
    Tetar, Shyama U.
    Bohoudi, Omar
    Senan, Suresh
    Palacios, Miguel A.
    Oei, Swie S.
    van der Wel, Antoinet M.
    Slotman, Berend J.
    van Moorselaar, R. Jeroen A.
    Lagerwaard, Frank J.
    Bruynzeel, Anna M. E.
    CANCERS, 2020, 12 (10) : 1 - 11
  • [47] A body mass index-based method for "MR-only" abdominal MR-guided adaptive radiotherapy
    Rippke, Carolin
    Renkamp, C. Katharina
    Stahl-Arnsberger, Christiane
    Miltner, Annette
    Buchele, Carolin
    Hoerner-Rieber, Juliane
    Ristau, Jonas
    Alber, Markus
    Debus, Juergen
    Klueter, Sebastian
    ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK, 2024, 34 (03): : 456 - 467
  • [48] Tumor control after MR-guided adaptive stereotactic radiotherapy for adrenal metastases
    Schneiders, F.
    Van Vliet, C.
    Palacios, M. A.
    Slotman, B. J.
    Lagerwaard, F. J.
    Bruynzeel, A. M.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S35 - S36
  • [49] Feasibility and first clinical Experience with an adaptive, MR-guided SBRT of Liver Tumors
    Rogowski, P.
    von Bestenbostel, R.
    Walter, F.
    Straub, K.
    Nierer, L.
    Landry, G.
    Reiner, M.
    Kurz, C.
    Auernhammer, C.
    Belka, C.
    Niyazi, M.
    Corradini, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S180 - S181
  • [50] Retrospective evaluation of usefulness of MR-guided adaptive radiotherapy of gastric MALT lymphoma
    Okuma, K.
    Okamoto, H.
    Iijima, K.
    Nishioka, F.
    Kashihara, T.
    Shima, S.
    Uematsu, M.
    Igaki, H.
    Nakayama, Y.
    Itami, J.
    Murakami, N.
    Nakamura, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S763 - S764